BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maik-Rachline G, Lifshits L, Seger R. Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation. Int J Mol Sci 2020;21:E6102. [PMID: 32847129 DOI: 10.3390/ijms21176102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Gao M, Gao D, Guo Y, Gao Z, Gao X, Wang J, Qiao M. Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations. Front Pharmacol 2022;13:941270. [DOI: 10.3389/fphar.2022.941270] [Reference Citation Analysis]
2 Hashimoto T, Kondo N, Makino A, Kiyono Y, Temma T. Radiobrominated probe targeting activated p38α in inflammatory diseases. Ann Nucl Med. [DOI: 10.1007/s12149-022-01764-2] [Reference Citation Analysis]
3 Zhang S, Liang Y, Yao J, Li DF, Wang LS. Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs. Front Pharmacol 2022;13:833588. [PMID: 35677444 DOI: 10.3389/fphar.2022.833588] [Reference Citation Analysis]
4 Hein MJA, Kvansakul M, Lay FT, Phan TK, Hulett MD. Defensin-lipid interactions in membrane targeting: mechanisms of action and opportunities for the development of antimicrobial and anticancer therapeutics. Biochem Soc Trans 2022:BST20200884. [PMID: 35015081 DOI: 10.1042/BST20200884] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 García-Hernández L, García-Ortega MB, Ruiz-Alcalá G, Carrillo E, Marchal JA, García MÁ. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. Int J Mol Sci 2021;23:370. [PMID: 35008796 DOI: 10.3390/ijms23010370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ma R, Liu Y, Che X, Li C, Wen T, Hou K, Qu X. Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3. Cancer Lett 2021;527:127-39. [PMID: 34923044 DOI: 10.1016/j.canlet.2021.12.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Maik-Rachline G, Wortzel I, Seger R. Alternative Splicing of MAPKs in the Regulation of Signaling Specificity. Cells 2021;10:3466. [PMID: 34943973 DOI: 10.3390/cells10123466] [Reference Citation Analysis]
8 Wang S, Wang A, Zhang Y, Zhu K, Wang X, Chen Y, Wu J. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas. BMC Endocr Disord 2021;21:235. [PMID: 34814904 DOI: 10.1186/s12902-021-00900-9] [Reference Citation Analysis]
9 Zhou P, Shi W, He XY, Du QY, Wang F, Guo J. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics. Pharm Biol 2021;59:1480-9. [PMID: 34714209 DOI: 10.1080/13880209.2021.1992448] [Reference Citation Analysis]
10 Morgan D, Berggren KL, Spiess CD, Smith HM, Tejwani A, Weir SJ, Lominska CE, Thomas SM, Gan GN. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer. Mol Carcinog 2021. [PMID: 34559922 DOI: 10.1002/mc.23348] [Reference Citation Analysis]
11 Huang Y, Wang Y, Wang Y, Wang N, Duan Q, Wang S, Liu M, Bilal MA, Zheng Y. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. J Invest Dermatol 2021:S0022-202X(21)01670-5. [PMID: 34358528 DOI: 10.1016/j.jid.2021.07.163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chatterjee S, Yabaji SM, Rukhlenko OS, Bhattacharya B, Waligurski E, Vallavoju N, Ray S, Kholodenko BN, Brown LE, Beeler AB, Ivanov AR, Kobzik L, Porco JA Jr, Kramnik I. Channeling macrophage polarization by rocaglates increases macrophage resistance to Mycobacterium tuberculosis. iScience 2021;24:102845. [PMID: 34381970 DOI: 10.1016/j.isci.2021.102845] [Reference Citation Analysis]
13 Lampiasi N, Russo R, Kireev I, Strelkova O, Zhironkina O, Zito F. Osteoclasts Differentiation from Murine RAW 264.7 Cells Stimulated by RANKL: Timing and Behavior. Biology (Basel) 2021;10:117. [PMID: 33557437 DOI: 10.3390/biology10020117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Sanz-Ezquerro JJ, Cuenda A. p38 Signalling Pathway. Int J Mol Sci 2021;22:1003. [PMID: 33498296 DOI: 10.3390/ijms22031003] [Reference Citation Analysis]
15 Liu P, Gao Q, Guan L, Sheng W, Hu Y, Gao T, Jiang J, Xu Y, Qiao H, Xue X, Liu S, Li T. Atorvastatin Attenuates Isoflurane-Induced Activation of ROS-p38MAPK/ATF2 Pathway, Neuronal Degeneration, and Cognitive Impairment of the Aged Mice. Front Aging Neurosci 2020;12:620946. [PMID: 33519423 DOI: 10.3389/fnagi.2020.620946] [Reference Citation Analysis]